INTRODUCTION
============

Several surgical techniques can be used to treat apical prolapse. These include sacrospinous ligament fixation via the vagina and abdominal colpofixation to the sacral promontory (i.e., sacral colpopexy) [@b1-cln_71p487],[@b2-cln_71p487].

Sacrospinous ligament fixation requires less surgical time and provides faster recovery than the alternatives, however, it also has a greater association with the onset of postoperative cystocele, which can be understood by the female patient as a failure of the technique [@b3-cln_71p487],[@b4-cln_71p487]. One method to minimize prolapse of the anterior wall (cystocele) after fixation to the sacrospinous ligament is the use of synthetic non-absorbable material (i.e., meshes) during surgery. Repairing a cystocele with non-absorbable polypropylene material is better than the traditional colporrhaphy and leads to a lower recurrence rate of anterior vaginal wall prolapse [@b3-cln_71p487].

However, the use of meshes is not free of risks or complications, the main risks being extrusion and dyspareunia [@b5-cln_71p487]. The International Urogynecological Association (IUGA) accepts the use of meshes in women who will undergo sacrospinous fixation, as these women generally have advanced stage prolapse or apical prolapse, and the benefits outweigh the risks under these conditions [@b6-cln_71p487]. The use of mesh in the anterior wall can also be employed for women undergoing sacrospinous ligament fixation in order to decrease the rate of anterior wall prolapse following the procedure. However, few studies have examined this association.

The objective of the current study was to compare the efficacy and safety of vaginal fixation to the sacrospinous ligament using mesh in the anterior wall and sacral colpopexy for the correction of apical prolapse. This comparison was made by analyzing the objective cure, complication and failure rates after each procedure.

MATERIALS AND METHODS
=====================

A retrospective design was used to evaluate the medical records of 89 women who underwent surgery for genital apical prolapse repair, 48 of whom underwent abdominal sacral colpopexy and 41 of whom underwent sacrospinous ligament fixation with mesh placement on the anterior wall of the vagina. All procedures were performed at the Department of Obstetrics and Gynecology, School of Medical Sciences, University of Campinas (Unicamp), from 2005 to 2012. This study was approved by the Ethics Committee of the Faculty of Medical Sciences under number 152451113.8.00005404 on 08/08/2013.

The two standard procedures used for apical prolapse at the hospital were abdominal sacral colpopexy and sacrospinous ligament fixation without anterior wall correction. The women were informed about the two procedures and were free to choose which one they preferred. All surgeries were performed by the same operator (20 years of experience, more than 5000 surgeries). The techniques are described below.

Sacrospinous ligament fixation with mesh placement on the anterior wall with a double transobturator pass.

All of the women who had a uterus underwent vaginal hysterectomy. After opening the posterior vaginal mucosa, two stitches with Vicryl thread were passed bilaterally through the sacrospinous ligament using direct visualization, followed by fixing of the stitches in the vaginal vault. Then, a longitudinal opening was made in the anterior vaginal mucosa. Dissection of the vesico-vaginal fascia was performed bilaterally up to both tendon arches.

Gynecare Prolift^TM^ mesh kits (Johnson & Johnson Company, Somerville, New Jersey, USA) were used. The needles from a mesh kit were placed bilaterally along the superomedial rim of the transobturator foramen, and the upper extension arms of the mesh were fixed to each side of the needles with externalization up to the entry point of the genitofemoral fold. An additional two needles were placed bilaterally through the inferomedial rim of the transobturator foramen (with a 2 cm lateral entrance hole and at 2 cm under the genitofemoral fold at the height of the external urethral meatus; the exit path was through a hole in the anterior vaginal mucosa). The lower extension arms of the mesh were placed on each side of the needles, with an exit path that reached up to the entrance point of the genitofemoral fold. The upper rim of the mesh was placed on the vesico-vaginal fascia just below the bladder neck using 0 or 1 Polyglactin 910 thread. The lower rim was placed on the vaginal vault parametria using two Prolene 2.0 stitches. After this procedure, the anterior vaginal mucosa was closed with 910 Polyglactin 0 threads. The vault was fixed using knots on the sacrospinous ligament. The mesh was adjusted without tension. The mesh extension arms were cut close to the skin, which was closed with catgut 2.0. The mesh used was a polypropylene, macroporous and monofilament mesh.

Abdominal sacral colpopexy
--------------------------

The skin was incised up to the Pfannenstiel or infraumbilical median if a woman presented with this type of prior incision. All of the women who had a uterus underwent abdominal hysterectomy. The sacral retroperitoneum was opened to reveal the promontory periosteum. Mesh was placed between the sacral promontory and the vaginal vault, correcting anterior and posterior defects when present. The fixation of the mesh on the promontory periosteum and vault was performed using Prolene 0. After fixation, the mesh was covered with the parietal peritoneum so that the mesh would not be exposed in the abdominal cavity. The pelvic wall was then closed in planes. There were no anterior wall vaginal corrections in the abdominal sacral colpopexy group. Women with posterior prolapse underwent vaginal wall reconstruction.

The evaluation of a prolapse was conducted using the Quantification System of Pelvic Organ Prolapse (POP-Q). Study data were collected using an elaborate form that included dependent variables such as efficacy (defined by objective cure and failure rates), safety (defined by immediate complications such as intraoperative bleeding and infection), and late complications (occurring within 6 weeks after surgery) such as pain, mesh extrusion, infection, vaginal bleeding, vaginal discharge, fistulas and dyspareunia. The control variables included degree of uterine prolapse, age, parity, race, body mass index (BMI), comorbidities, previous surgeries, smoking status and use of hormone replacement therapy. Objective cure was defined as the absence of a POP-Q stage prolapse less than or equal to 2. The first post-operative review was performed 6 weeks after surgery and 6 follow-up visits were conducted over 6 months.

The points from the POP-Q (7,8) were assessed during the first visit and at the post-operative review. The POP-Q was applied before surgery and at a later revaluation. Genital prolapse was assessed qualitatively in stages and quantitatively in centimeters. Cure, complication and recurrence rates were evaluated through simple prevalence and were compared using the chi-square test or Fisher\'s exact test. For non-parametric variables, the Mann-Whitney test was used. For the variables that were evaluated during follow-up, the Wilcoxon paired test for POP-Q measurements was used. The significance level was 5%, and SAS was used for data analysis was SAS.

RESULTS
=======

The median follow-up was 9 months for women who underwent sacrospinous ligament fixation and 6 months for the women who sacral colpopexy. The average age was 63.1 (±8.7) years for the women who underwent sacrospinous ligament fixation and 63 (±8.4) years for those who underwent sacral colpopexy, with no significant difference between the two groups (*p*=0.8373). In relation to the women included in the study, 40.4% had vault prolapse, 19% had previously underwent abdominal hysterectomy and 21.4% had previously underwent vaginal hysterectomy. There were no differences in these variables between the two groups ([Table 1](#t1-cln_71p487){ref-type="table"}).

Regarding the POP-Q classification system used for prolapse prior to surgery, most of the women (58.4%) had stage 3 apical prolapse ([Table 2](#t2-cln_71p487){ref-type="table"}). In assessing the presence of anterior wall prolapse prior to surgery, it was noted that there were differences between the two study groups (*p*\<0.0001).

Regarding prolapse stage after surgery, there was no difference between the groups regarding the presence of prolapse in the anterior wall. When evaluating apical prolapse, the authors found that there were 3 cases of failure in the women who had underwent sacrospinous ligament fixation. Considering the objective cure rate as less than or equal to stage 2 apical prolapse, the cure rate was 95.8%, with no difference between the groups (90.9% in the group who underwent sacrospinous ligament fixation and 100% in the group who underwent sacral colpopexy). There were only three cases of failure. All were in the group who underwent sacrospinous ligament fixation, and the average follow-up was 11.1 months ([Table 2](#t2-cln_71p487){ref-type="table"}).

In analyzing the immediate complications, the vast majority of the cases that underwent surgery presented no complications (93.2%), with no difference between the groups (*p*=0.9418). The most frequent complications were increased bleeding and a need for transfusion, with no difference between the groups ([Table 3](#t3-cln_71p487){ref-type="table"}). There were no vascular, intestinal or urinary tract injuries.

Approximately 30% of the women had late complications (after 40 days). The most common complication was local pain, which was present only in the women who underwent the abdominal technique (25.6%) (*p*=0.001). Mesh exposure occurred in 9.1% of the total cohort: 18.4% of the women who underwent the vaginal procedure had mesh exposure, and none of the women who underwent the abdominal procedure had mesh exposure. This difference was significant between the groups (*p*=0.0052). Only 2 of the women (4.9%) who underwent sacral colpopexy presented with vaginal discharge (*p*=0.4948).

Most of the women did not experience postoperative apical prolapse (91% of the women who underwent colpofixation to the sacrospinous and 78.9% of the women who underwent sacral colpopexy did not have this complication). Regarding anterior wall prolapse, 9% of the women who underwent vaginal surgery had stage 3 prolapse ([Table 3](#t3-cln_71p487){ref-type="table"}).

When analyzing the POP-Q points, the authors observed a significant improvement in the Aa and Ba points in the anterior wall in both surgeries, with no difference between them ([Table 4](#t4-cln_71p487){ref-type="table"}). The average point C (point of apical prolapse) showed significant improvement in both of the surgical groups operated ([Table 4](#t4-cln_71p487){ref-type="table"} and [Figure 1](#f1-cln_71p487){ref-type="fig"}). Vaginal size after surgery was larger in the group who underwent the abdominal technique. The average vaginal size was 9.31 cm in the women who underwent sacral colpopexy and 8.15 cm in the vaginal surgery group (*p*=0.0174). However, there was no difference between the groups when considering the difference between the preoperative and postoperative values, which leads to the conclusion that there was no difference regarding vaginal size between the two surgeries ([Table 4](#t4-cln_71p487){ref-type="table"}).

DISCUSSION
==========

Genital prolapse can affect a woman's quality of life, impacing the psychological, social and financial aspects of her life [@b9-cln_71p487]. With the aging of the population, it is estimated that the number of cases of genital prolapse in the United States will double in the next 30 years [@b10-cln_71p487]. Anterior genital prolapse is the most prevalent; however, apical prolapse normally progresses with prolapses beyond the hymen and is therefore more symptomatic. Furthermore, providing apical support has an important role in sustaining the anterior wall because if insufficient support is provided, treatment to correct the anterior and posterior walls may be ineffective [@b11-cln_71p487].

The biggest failure in sacrospinous ligament fixation is anterior wall prolapse, probably due to the posterior deviation of the vaginal axis [@b4-cln_71p487],[@b12-cln_71p487],[@b13-cln_71p487]. In a previous study conducted using this technique, an anterior wall prolapse rate of 39.7% (12) was obtained. The literature shows an anterior wall prolapse rate ranging from 17.3 to 25.3% (4). In contrast, in the current study, a low anterior prolapse rate was found, with no difference between the two techniques used. This is likely due to the use of mesh in the anterior wall during sacrospinous ligament fixation. The superiority of using synthetic meshes has been well described in the literature [@b14-cln_71p487]-[@b16-cln_71p487]. One study of the use of synthetic mesh via a double pass on the transobturator foramen also had satisfactory results with regard to anterior wall prolapse [@b17-cln_71p487].

This study evaluated two techniques for the treatment of apical prolapse (uterine or vault): an abdominal technique that used fixation to the sacral promontory and a vaginal technique that used fixation of the vault to the sacrospinous ligament by employing vaginal mesh. The objective success rates were satisfactory for both types of surgery, and there were no differences in their anterior vaginal prolapse rates. Sacral colpopexy has been accepted as the gold standard for apical prolapse treatment. In a systematic review, the objective success rate of sacral colpopexy was greater than that for fixation to the sacrospinous ligament. The current study showed a similar objective cure rate for the two techniques, which confirms that both surgeries are effective for apical prolapse treatment.

Several kits have been developed to treat prolapses of several compartments; some of these kits try to avoid the transobturatorial passage [@b18-cln_71p487]-[@b20-cln_71p487]. The placement of needles on the transobturator foramen can cause injuries such as vascular and nerve damage, but it provides better mounting of mesh on the anterior wall and possibly better anatomical results. In the present study, there were no serious complications and both techniques were deemed safe. There were no vascular lesions or instances of organ damage. Vascular lesions and bleeding are rare events [@b21-cln_71p487]. Some reports have suggested that lesions are more frequent in sacral colpopexy surgery [@b22-cln_71p487], but this finding was not observed in our study because we had only two cases that required transfusion (one in each group).

Mesh use in prolapse surgery has received criticism due to the potential for adverse events related to its use. The most frequent adverse event reported is extrusion, which may lead to important disorders for cases with extrusion to an organ. The literature reports an extrusion, erosion or exposure rate of up to 29% with the use of vaginal mesh [@b23-cln_71p487]-[@b25-cln_71p487]. The exposure rate in the current study was lower than those reported in the literature for women undergoing vaginal procedures. All the exposure cases were in the vaginal mucosa and were small, avoiding the need for surgical intervention. Recently, the IUGA evaluated mesh erosion and showed that in asymptomatic women treatment is usually conservative [@b26-cln_71p487].

Another complication associated with the use of vaginal meshes is the presence of vaginal discharge. A study of women diagnosed with mesh extrusion noted that 30.9% complained of vaginal discharge. This confirms that the use of mesh may increase the incidence of vaginal discharge. However, in our current study, few women presented with vaginal discharge after surgery and all of them were in the group that underwent sacrospinous ligament fixation [@b27-cln_71p487].

The use of the above vaginal technique has been consistently associated with diminished vaginal length after surgery, which could result in dyspareunia and sexual dysfunction. One study that compared women who underwent sacrospinous ligament fixation and sacral colpopexy with controls (women) concluded that if increased vaginal length is desirable, sacral colpopexy is more appropriate [@b28-cln_71p487]. In the current study, however, no difference was noted between surgeries for vaginal shortening.

One limitation of the current study is that the women who underwent surgery were not homogenous with regard to prolapse stage prior to surgery. The women who underwent sacral colpopexy presented more advanced stages and thus had more serious conditions than those who underwent sacrospinous ligament fixation. This might explain why there was no difference in the success rates of the two surgeries. Another limitation of the study was the use of medical records, as there were many missing and unknown data. The strengths of this study include the decrease in anterior wall prolapse rate following the use of mesh in the anterior wall, which improved the results and decreased the overall failure rate.

In conclusion, sacrospinous ligament fixation and sacral colpopexy are effective and safe techniques for the treatment of apical genital prolapse, with similar cure rates for the apical compartment. Sacrospinous ligament fixation using mesh in the anterior vaginal wall showed cure and relapse rates in the anterior compartment that were similar to those found in women undergoing the abdominal technique. There were no serious complications, including those related to the use of mesh, in either operation.
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###### 

Characteristics and types of surgery.

                                    Surgery                           
  ---------------------------- ---- --------- ---- ------ ---- ------ ---------------------------------------------------
  **Race**                                                            0.0288
  White                        74   83.1      30   73.2   44   91.7   
  Black                        1    1.1       1    2.4    0    0.0    
  Brown                        14   15.7      10   24.4   4    8.3    
  **Gestation**                                                       0.0063
  0                            2    2.2       0    0.0    2    4.2    
  1                            1    1.1       0    0.0    1    2.1    
  2                            19   21.3      4    9.8    15   31.3   
  3 or more                    67   75.3      37   90.2   30   62.5   
  **Parturition**                                                     0.0155
  0                            2    2.2       0    0.0    2    4.2    
  1                            3    3.4       0    0.0    3    6.3    
  2                            21   23.6      6    14.6   15   31.3   
  3 or more                    63   70.8      35   85.4   28   58.3   
  **BMI**                                                             0.3365[\*](#tfn1-cln_71p487){ref-type="table-fn"}
  Unknown                      8              4           4           
  Normal                       26   32.1      14   37.8   12   27.3   
  Obesity                      24   29.6      12   32.4   12   27.3   
  Overweight                   31   38.3      11   29.7   20   45.5   
  **Tabagism**                                                        0.7467
  Unknown                      4              3           1           
  No                           75   88.2      33   86.8   42   89.4   
  Yes                          10   11.8      5    13.2   5    10.6   
  **Comorbidities**                                                   0.5217[\*](#tfn1-cln_71p487){ref-type="table-fn"}
  Unknown                      1              0           1           
  No                           25   28.4      13   31.7   12   25.5   
  Yes                          63   71.6      28   68.3   35   74.5   
  **Abdominal hysterectomy**                                          0.9361[\*](#tfn1-cln_71p487){ref-type="table-fn"}
  Unknown                      5              5           0           
  No                           68   81        29   80.6   39   81.3   
  Yes                          16   19        7    19.4   9    18.8   
  **Vaginal hysterectomy**                                            0.7011[\*](#tfn1-cln_71p487){ref-type="table-fn"}
  Unknown                      5              5           0           
  No                           66   78.6      29   80.6   37   77.1   
  Yes                          18   21.4      7    19.4   11   22.9   

Chi square/\* Fisherߣs exact.

BMI Bone Mass Index.

###### 

Grades of apical prolapse before and after surgery and cure rates.

                                            Surgery                           
  ------------------------------------ ---- --------- ---- ------ ---- ------ ----------------------------------------------------
  **Anterior stage before surgery**                                           \< 0.0001
  unknown                              5              1           4           
  0                                    1    1.2       1    2.5    0    0      
  II                                   7    8.3       0    0      7    15.9   
  III                                  63   75        37   92.5   26   59.1   
  IV                                   13   15.5      2    5      11   25     
  **Posterior stage before surgery**                                          0.002
  unknown                              10             5           5           
  0                                    17   21.5      6    16.7   11   25.6   
  I                                    4    5.1       3    8.3    1    2.3    
  II                                   4    5.1       0    0      4    9.3    
  III                                  43   54.4      26   72.2   17   39.5   
  IV                                   11   13.9      1    2.8    10   23.3   
  **Apical stage before surgery**                                             0.0034
  II                                   20   22.7      15   36.6   5    10.6   
  III                                  48   54.5      20   48.8   28   59.6   
  IV                                   17   19.3      4    9.8    13   27.7   
  **Anterior stage after surgery**                                            0.2970[\*](#tfn10-cln_71p487){ref-type="table-fn"}
  unknown                              18             8           10          
  0                                    53   74.6      23   69.7   30   7.9    
  I                                    3    4.2       1    3      2    5.3    
  II                                   12   16.9      6    18.2   6    15.8   
  III                                  3    4.2       3    9.1    0    0      
  **Posterior stage after surgery**                                           0.0454[\*](#tfn10-cln_71p487){ref-type="table-fn"}
  unknown                              17             8           9           
  0                                    59   81.9      26   78.8   33   84.6   
  I                                    4    5.6       0    0      4    10.3   
  II                                   7    9.7       5    15.2   2    5.1    
  III                                  2    2.8       2    6.1    0    0      
  **Apical stage after surgery**                                              0.0477[\*](#tfn10-cln_71p487){ref-type="table-fn"}
  unknown                              18             8           10          
  0                                    66   93        30   90.9   36   94.7   
  I                                    2    2.8       0    0      2    5.3    
  III                                  3    4.2       3    9.1    0    0      
  **Objective impression**                                                    0.0955
  unknown                              18             8           10          
  Cured                                68   95.8      30   90.9   38   100    
  non cured                            3    4.2       3    9.1    0    0      

Chi square/\* Fisher's exact.

###### 

Immediate and late complications after surgery.

                                    Surgery                             
  ---------------------------- ---- --------- ---- ------- ---- ------- ---------------------------------------------------
  **Immediate complication**                                            0.9418
  Infection                    1              0            1            
  None                         82   93.2      38   92.7    44   93.6    
  Other                        1    1.1       1    2.4     0    0.0     
  Blood loss                   3    3.4       1    2.4     2    4.3     
  Transfusion                  2    2.3       1    2.4     1    2.1     
  **Late complications**                                                0.8614[\*](#tfn3-cln_71p487){ref-type="table-fn"}
  Unknown                      12             3            9            
  No                           54   70.1      27   71.1    27   69.2    
  Yes                          23   29.9      11   28.9    12   30.8    
  **Infection**                                                         1.0000
  Unknown                      12             3            9            
  No                           73   94.8      36   94.7    37   94.9    
  Yes                          4    5.2       2    5.3     2    5.1     
  **Local pain**                                                        0.0010
  Unknown                      12             3            9            
  No                           67   87.0      38   100.0   29   74.4    
  Yes                          10   13.0      0    0.0     10   25.6    
  **Mesh exposure**                                                     0.0866
  Unknown                      12             3            9            
  No                           68   88.3      31   81.6    37   94.9    
  Yes                          9    11.7      7    18.4    2    5.1     
  **Blood loss**                                                        0.4935[\*](#tfn3-cln_71p487){ref-type="table-fn"}
  Unknown                      12             3            9            
  No                           75   97.4      38   100.0   37   94.9    
  Yes                          2    2.6       0    0.0     2    5.1     
  **Vaginal discharge**                                                 0.4948
  Unknown                      11             0            11           
  No                           76   97.4      39   95.1    37   100.0   
  Yes                          2    2.6       2    4.9     0    0.0     

Chi square/\* Fisherߣs exact.

###### 

Comparison of Pelvic Organ Prolapse Quantification points before and in the last follow-up visit after surgery.

  POP-Q point (difference between before and after surgery)   Sacrospinous   Sacral Colpopexy                               
  ----------------------------------------------------------- -------------- ------------------ ------ ---- -------- ------ ------------
  Aa                                                          25             -4.8               1.85   13   -3.46    2.15   0.0794
  Ba                                                          24             -7.79              2.43   13   -6.08    3.35   0.1369
  C                                                           25             -11                3.82   13   -12.69   5.01   **0.0459**
  Total vaginal length                                        25             -1.28              1.93   15   -0.4     1.3    0.1587
  Ap                                                          25             -1.12              2.91   13   -1.46    2.11   0.8137
  Bp                                                          25             -4.52              4.52   13   -4.38    3.75   1.0000

*p* value: Mann-Whitney.
